MEI Pharma, Inc.
Combination therapy
Last updated:
Abstract:
Provided herein are methods of treating diseases, such as cancer, using a combination therapy. In certain embodiments, the methods comprise administering an effective amount of a phosphoinositide-3-kinase (PI3K) inhibitor and an effective amount of a CD20 inhibitor to a patient.
Status:
Grant
Type:
Utility
Filling date:
14 Aug 2018
Issue date:
7 Jun 2022